Your session is about to expire
← Back to Search
Food support for Type 2 Diabetes (NU-DSMP Trial)
NU-DSMP Trial Summary
This trial will test if providing food support and case-management to people with type 2 diabetes who are enrolled in Medicaid will help improve their glycemic control and other outcomes.
- Type 2 Diabetes
NU-DSMP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NU-DSMP Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are participants being enrolled for this clinical exploration presently?
"The data posted on clinicaltrials.gov is indicative of this trial's requirement for participants; it was first published in November 2021 and recently updated in October 2022."
How many participants may enroll in this experiment?
"Indeed, the information on clinicaltrials.gov reveals that this medical trial is actively recruiting participants and has been since November 8th 2021. The study was last revised on October 14th 2022 and requires 72 patients to be recruited from a single location."
What are the fundamental goals of this clinical experiment?
"This medical trial's primary end-point, evaluated over the course of twelve weeks from Baseline, is a variation in Hemoglobin A1c (HbA1c). Secondary outcomes include alteration in participants that have achieved glucose control defined by HbA1c levels being below 9%, adjustment to depressive symptoms gauged with PHQ-8 scores ranging from 0 to 24, and changes in those experiencing low or very low food security ascertained through 3 affirmative answers on the USDA US Household Food Security Survey Module."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger